Skip to main content

Table 2 Comparison of the questionnaires between AIBD patients and non-AIBD controls

From: Ocular surface disorders affect quality of life in patients with autoimmune blistering skin diseases: a cross-sectional study

 

AIBD patients

Non-AIBD controls

P value

(n = 25)

(n = 24)

SF-36

59.64 ± 17.32

79.04 ± 17.97

 < 0.001

 MSC

61.56 ± 19.78

77.54 ± 19.90

0.007

 PCS

57.96 ± 20.56

80.88 ± 19.11

 < 0.001

Physical functioning

83.80 ± 15.63

92.08 ± 10.62

0.036

Physical role functioning

33.00 ± 42.52

83.33 ± 38.07

 < 0.001

Bodily pain

74.96 ± 24.98

86.58 ± 21.43

0.088

General health perceptions

45.00 ± 21.11

55.42 ± 23.82

0.112

Vitality

63.00 ± 16.77

59.38 ± 26.43

0.568

Social role functioning

68.28 ± 21.61

86.96 ± 19.03

0.002

Emotional role functioning

47.92 ± 47.21

80.50 ± 35.36

0.009

Mental health

65.20 ± 21.43

73.00 ± 17.47

0.170

HADS

 Anxiety

5.96 ± 3.40

3.75 ± 3.23

0.024

 Depression

7.44 ± 4.00

6.13 ± 4.49

0.284

PSQI

6.68 ± 3.96

7.54 ± 4.45

0.478

PSQI level, n (%)

  

0.355

 Normal (scores < 5)

9 (36.0%)

5 (20.8%)

 

 Abnormal (scores ≥ 5)

16 (64.0%)

19 (79.2%)

 

HAQ-DI

0.16 ± 0.47

0.04 ± 0.20

0.264

  1. SF-36 Medical Outcomes Study 36-Item Short Form questionnaire, PCS Physical component summary, MCS Mental component summary, HADS Hospital Anxiety and Depression Scale, PSQI Pittsburgh Sleep Quality Index, HAQ-DI Health Assessment Questionnaire-Disability Index, AIBD Autoimmune blistering skin diseases
  2. Significant differences (P value < 0.05) are bolded